obscurin like cytoskeletal adaptor 1
آخر تحديث 5 Jul 2022
يتوافق مع الإرشادات التحريرية
- تنزيلتنزيل
- مشاركة
- Language
- نقاش
- Ask Patient
- نسخة صوتية
- أضف إلى المصادر المفضلة على جوجل
ال OBSL1 gene provides instructions for making a protein that is thought to help maintain normal levels of another protein called cullin-7, which is produced from the CUL7 gene. The cullin-7 protein plays a role in the ubiquitin-proteasome system, which is the cell machinery that breaks down (degrades) unwanted proteins.
اختيارات الفيديو لـ Genesمكتبة الفيديو
Normal function
ال OBSL1 gene provides instructions for making a protein that is thought to help maintain normal levels of another protein called cullin-7, which is produced from the CUL7 gene. The cullin-7 protein plays a role in the ubiquitin-proteasome system, which is the cell machinery that breaks down (degrades) unwanted proteins.
Cullin-7 helps assemble a complex known as an E3 ubiquitin ligase. This complex tags damaged and excess proteins with molecules called ubiquitin. Ubiquitin serves as a signal to specialized cell structures known as proteasomes, which attach (bind) to the tagged proteins and degrade them. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins. This system also regulates the level of proteins involved in several critical cell activities such as the timing of cell division and growth. In particular, the OBSL1 protein and cullin-7 are thought to help regulate proteins involved in the body's response to growth hormones, although their specific role in this process is unknown.
Conditions referring to this gene or chromosome
Other names
KIAA0657
obscurin-like protein 1 isoform 1 precursor
obscurin-like protein 1 isoform 2 precursor
obscurin-like protein 1 isoform 3 precursor
Related patient information and medicines

Patient information leaflet
هل يمكنني تناول أتورفاستاتين ومكملات الألياف معًا؟
Taking fibre supplements at the same time as atorvastatin can lower the amount of medicine your body absorbs. Using ot... Our Medicines Interaction Checker helps تعتقد check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
هل يمكنني تناول ألوغليبتين ومكملات الألياف معًا؟
Taking fibre supplements at the same time as alogliptin may slightly lower the amount of medicine your body absorbs. لدينا مدقق تفاعلات الأدوية helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and ... Disclaimer.

Patient information leaflet
هل يمكنني تناول ألوجليبتين وريبيلسوس معًا؟
Taking alogliptin and Rybelsus (semaglutide) together can significantly increase the risk of your blood sugar dropping too low (hypoglycaemia). Additionally, both medicines work in a similar way on the same hormonal pathway, and using them together is generally not recommended because it does not provide extra benefit but increases the risk of.

Patient information leaflet
صدفية الأظافر
What is. Psoriatic nail مرض is a type of psoriasis. It is not caused by infection and you cannot pass it on to anyone else. Psoriasis is a common skin condition that usually causes patches (plaques) of red, scaly skin but sometimes affects the nails and cuticles. There is also a form of arthritis that is linked to psoriasis, called psoriatic.

Patient information leaflet
هل يمكنني تناول الجلوكومانان والنكسبلانون معًا؟
Glucomannan is a type of fibre that can slow down or reduce how much of your contraceptive medication is absorbed into your bloodstream. This could potentially make the Nexplanon implant less effective at preventing pregnancy. Why this happens Glucomannan is a highly absorbent fibre that forms a thick gel in the stomach and intestines. This gel.

Patient information leaflet
خلل التوتر العضلي
A dystonia هو a lasting or frequently recurring and unwanted (involuntary) muscle contraction. It can affect one or more muscles in the body. There is no cure; however, there are different types of treatment which can help. These vary with the type of dystonia that you have. What is dystonia. A dystonia is lasting unwanted (involuntary) muscle.
قراءة إضافية ومراجع
- obscurin like cytoskeletal adaptor 1; MedlinePlus, National Library of Medicine.
- Akilapa R, Irving M, Holder-Espinasse M. 3-M Syndrome. 2002 Mar 25 [updated 2025 Feb 27]. In: Adam MP, Bick S, Mirzaa GM, Wallace SE, Amemiya A, editors. GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2026. Available from http://www.ncbi.nlm.nih.gov/books/NBK1481/
- Clayton PE, Hanson D, Magee L, Murray PG, Saunders E, Abu-Amero SN, Moore GE, Black GC. Exploring the spectrum of 3-M syndrome, a primordial short stature disorder of disrupted ubiquitination. Clin Endocrinol (Oxf). 2012 Sep;77(3):335-42. doi: 10.1111/j.1365-2265.2012.04428.x.
- Hanson D, Murray PG, Black GC, Clayton PE. The genetics of 3-M syndrome: unravelling a potential new regulatory growth pathway. Horm Res Paediatr. 2011;76(6):369-78. doi: 10.1159/000334392. Epub 2011 Nov 29.
- Hanson D, Murray PG, Coulson T, Sud A, Omokanye A, Stratta E, Sakhinia F, Bonshek C, Wilson LC, Wakeling E, Temtamy SA, Aglan M, Rosser EM, Mansour S, Carcavilla A, Nampoothiri S, Khan WI, Banerjee I, Chandler KE, Black GC, Clayton PE. Mutations in CUL7, OBSL1 and CCDC8 in 3-M syndrome lead to disordered growth factor signalling. J Mol Endocrinol. 2012 Oct 30;49(3):267-75. doi: 10.1530/JME-12-0034. Print 2012 Dec.
- Hanson D, Murray PG, Sud A, Temtamy SA, Aglan M, Superti-Furga A, Holder SE, Urquhart J, Hilton E, Manson FD, Scambler P, Black GC, Clayton PE. The primordial growth disorder 3-M syndrome connects ubiquitination to the cytoskeletal adaptor OBSL1. Am J Hum Genet. 2009 Jun;84(6):801-6. doi: 10.1016/j.ajhg.2009.04.021. Epub 2009 May 28.
- Huber C, Fradin M, Edouard T, Le Merrer M, Alanay Y, Da Silva DB, David A, Hamamy H, van Hest L, Lund AM, Michaud J, Oley C, Patel C, Rajab A, Skidmore DL, Stewart H, Tauber M, Munnich A, Cormier-Daire V. OBSL1 mutations in 3-M syndrome are associated with a modulation of IGFBP2 and IGFBP5 expression levels. Hum Mutat. 2010 Jan;31(1):20-6. doi: 10.1002/humu.21150.
تاريخ المقال
المقال متاح أيضًا باللغة الإنجليزية, الألمانية, إسبانية, الفرنسية, إيطالي, البرتغالية, الهندية, العبرية, العربية ,، و السويدية.
5 Jul 2022 | أحدث إصدار
1 Jun 2018 | نُشر في الأصل
شارك أفكارك أو تجاربك مع الآخرين في مجتمعات المرضى.
اشترك في النشرة الإخبارية للمرضى
جرعتك الأسبوعية من النصائح الصحية الواضحة والموثوقة - مكتوبة لمساعدتك على الشعور بالاطلاع والثقة والتحكم.
من خلال الاشتراك، فإنك تقبل سياسة الخصوصية. يمكنك إلغاء الاشتراك في أي وقت. نحن لا نبيع بياناتك أبدًا.

